Ethical and scientific issues in studying the safety of approved drugs / Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Year of Publication: | 2012 |
Language: | English |
Online Access: | |
Physical Description: | xvi, 275 p. :; ill. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
5003564274 |
---|---|
ctrlnum |
(MiAaPQ)5003564274 (Au-PeEL)EBL3564274 (CaPaEBR)ebr10606354 (CaONFJC)MIL394890 (OCoLC)811594850 |
collection |
bib_alma |
record_format |
marc |
spelling |
Ethical and scientific issues in studying the safety of approved drugs [electronic resource] / Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies. Washington, D.C. : National Academies Press, c2012. xvi, 275 p. : ill. Includes bibliographical references. Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. Drugs Testing Moral and ethical aspects United States. Clinical trials Moral and ethical aspects United States. Drug approval United States. Electronic books. Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs. Institute of Medicine (U.S.). Board on Population Health and Public Health Practice. National Academies Press (U.S.) ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3564274 Click to View |
language |
English |
format |
Electronic eBook |
author2 |
Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs. Institute of Medicine (U.S.). Board on Population Health and Public Health Practice. National Academies Press (U.S.) ProQuest (Firm) |
author_facet |
Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs. Institute of Medicine (U.S.). Board on Population Health and Public Health Practice. National Academies Press (U.S.) ProQuest (Firm) Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs. Institute of Medicine (U.S.). Board on Population Health and Public Health Practice. National Academies Press (U.S.) ProQuest (Firm) |
author2_role |
TeilnehmendeR TeilnehmendeR TeilnehmendeR TeilnehmendeR |
author_corporate |
Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs. Institute of Medicine (U.S.). Board on Population Health and Public Health Practice. National Academies Press (U.S.) ProQuest (Firm) |
title |
Ethical and scientific issues in studying the safety of approved drugs |
spellingShingle |
Ethical and scientific issues in studying the safety of approved drugs |
title_full |
Ethical and scientific issues in studying the safety of approved drugs [electronic resource] / Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies. |
title_fullStr |
Ethical and scientific issues in studying the safety of approved drugs [electronic resource] / Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies. |
title_full_unstemmed |
Ethical and scientific issues in studying the safety of approved drugs [electronic resource] / Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies. |
title_auth |
Ethical and scientific issues in studying the safety of approved drugs |
title_new |
Ethical and scientific issues in studying the safety of approved drugs |
title_sort |
ethical and scientific issues in studying the safety of approved drugs |
publisher |
National Academies Press, |
publishDate |
2012 |
physical |
xvi, 275 p. : ill. |
callnumber-first |
R - Medicine |
callnumber-subject |
RM - Therapeutics and Pharmacology |
callnumber-label |
RM301 |
callnumber-sort |
RM 3301.27 E84 42012 |
genre |
Electronic books. |
genre_facet |
Electronic books. |
geographic_facet |
United States. |
url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3564274 |
illustrated |
Illustrated |
oclc_num |
811594850 |
work_keys_str_mv |
AT instituteofmedicineuscommitteeonethicalandscientificissuesinstudyingthesafetyofapproveddrugs ethicalandscientificissuesinstudyingthesafetyofapproveddrugs AT instituteofmedicineusboardonpopulationhealthandpublichealthpractice ethicalandscientificissuesinstudyingthesafetyofapproveddrugs AT nationalacademiespressus ethicalandscientificissuesinstudyingthesafetyofapproveddrugs AT proquestfirm ethicalandscientificissuesinstudyingthesafetyofapproveddrugs |
status_str |
n |
ids_txt_mv |
(MiAaPQ)5003564274 (Au-PeEL)EBL3564274 (CaPaEBR)ebr10606354 (CaONFJC)MIL394890 (OCoLC)811594850 |
is_hierarchy_title |
Ethical and scientific issues in studying the safety of approved drugs |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField noLinkedField |
_version_ |
1792330884987224064 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01815nam a2200385Ia 4500</leader><controlfield tag="001">5003564274</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">120529s2012 dcua sb 000 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2012021854</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309218139</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309218146</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5003564274</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL3564274</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10606354</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL394890</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)811594850</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM301.27</subfield><subfield code="b">.E84 2012</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Ethical and scientific issues in studying the safety of approved drugs</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">c2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xvi, 275 p. :</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical trials</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug approval</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Board on Population Health and Public Health Practice.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Academies Press (U.S.)</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3564274</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |